IndraLab
Statements
reach
"As shown in XREF_FIG, the expression of MDM2 in A549 cells was upregulated to 1.5 times that in the negative control group (P = 0.003) after inhibitor-miR1273f transfection, and mimic-miR1273f transfection significantly downregulated the expression of MDM2 to 2/3 of that in negative control group (P = 0.035)."
reach
"Recent studies have also shown that a single nucleotide polymorphism (SNP) in the MDM2 promoter (SNP309), which slightly increases MDM2 levels (by ~ 2-fold), significantly impacts upon tumorigenesis through attenuating p53 function in both human beings and animal models [XREF_BIBR, XREF_BIBR]."
reach
"The importance of MDM2 in neuroblastoma pathogenesis is further illustrated by studies which have observed that a SNP within the MDM2 promoter (SNP309 T to G) that can lead to higher expression of MDM2 and greater inhibition of p53, is associated with poor survival in neuroblastoma, in particular stage 4 patients with MYCN amplification."
reach
"There are a number of pre-clinical studies demonstrating the promise of targeting MDM2 via PPIs in cancers with either high endogenous MDM2 expression or targeting MDM2 following induction of MDM2 expression via DNA damaging agents [XREF_BIBR, XREF_BIBR, XREF_BIBR, XREF_BIBR, XREF_BIBR, XREF_BIBR, XREF_BIBR]."
reach
"RPS27a knockdown increased the expression of MDM2 and p53 (Fig. 4E; comparison of lane 3 with lane 2 in lower panels), MDM2 ubiquitinated p53, whereas RPS27a knockdown inhibited this ubiquitination that led to p53 accumulation (Fig. 4E; comparison of lane 3 with lane 2 in upper panel)."
reach
"RNA interference showed that p53 knockdown increased the protein level of Gli1 but decreased the level of MDM2, and enhanced cell invasion and migration in wild-type p53 Capan-2 cells; whereas Gli1 or MDM2 knockdown did not change p53 expression, but decreased the protein level of MDM2 or Gli1, respectively, and inhibited cell invasion and migration in mutant p53 PANC-1 cells."
reach
"A MDM2 single nucleotide polymorphism at the 309 th nucleotide in the first intron (rs2279744), with a T to G change, could increase the affinity for stimulatory protein (Sp) 1 binding and result in increased MDM2 expression and subsequent attenuation of the P53 pathway XREF_BIBR."